Global Pertussis Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Pertussis Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

According to APO Research, The global Pertussis Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.
The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Pertussis Vaccine segment by Type

Whole-cell Vaccines
Acellular Vaccines
Pertussis Vaccine segment by Application

12 Months Below
12 Months Above
Pertussis Vaccine by Distribution Channel

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pertussis Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Pertussis Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Pertussis Vaccine Market by Type
1.3.1 Whole-cell Vaccines
1.3.2 Acellular Vaccines
1.4 Global Pertussis Vaccine Market Size by Type
1.4.1 Global Pertussis Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Pertussis Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Pertussis Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Pertussis Vaccine Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Pertussis Vaccine Revenue (2019-2024)
3.2 Global Top Players by Pertussis Vaccine Sales (2019-2024)
3.3 Global Top Players by Pertussis Vaccine Price (2019-2024)
3.4 Global Pertussis Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Pertussis Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Pertussis Vaccine Company, Product Type & Application
3.7 Global Pertussis Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Pertussis Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Pertussis Vaccine Tier 1, Tier 2, and Tier 3
4 Pertussis Vaccine Regional Status and Outlook
4.1 Global Pertussis Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Pertussis Vaccine Historic Market Size by Region
4.2.1 Global Pertussis Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Pertussis Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Pertussis Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Pertussis Vaccine Forecasted Market Size by Region
4.3.1 Global Pertussis Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Pertussis Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Pertussis Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Pertussis Vaccine by Application
5.1 Pertussis Vaccine Market by Application
5.1.1 12 Months Below
5.1.2 12 Months Above
5.2 Global Pertussis Vaccine Market Size by Application
5.2.1 Global Pertussis Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Pertussis Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Pertussis Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Pertussis Vaccine Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Comapny Information
6.1.2 Sanofi Pasteur Business Overview
6.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Pertussis Vaccine Product Portfolio
6.2.5 GSK Recent Developments
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Comapny Information
6.3.2 Mitsubishi Tanabe Pharma Business Overview
6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments
6.4 Wuhan Institute of Biological Products
6.4.1 Wuhan Institute of Biological Products Comapny Information
6.4.2 Wuhan Institute of Biological Products Business Overview
6.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
6.4.5 Wuhan Institute of Biological Products Recent Developments
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Comapny Information
6.5.2 Walvax Biotechnology Business Overview
6.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
6.5.5 Walvax Biotechnology Recent Developments
6.6 Minhai Biotechnology
6.6.1 Minhai Biotechnology Comapny Information
6.6.2 Minhai Biotechnology Business Overview
6.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
6.6.5 Minhai Biotechnology Recent Developments
6.7 KM Biologics
6.7.1 KM Biologics Comapny Information
6.7.2 KM Biologics Business Overview
6.7.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 KM Biologics Pertussis Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments
6.8 Chengdu Institute of Biological Products
6.8.1 Chengdu Institute of Biological Products Comapny Information
6.8.2 Chengdu Institute of Biological Products Business Overview
6.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
6.8.5 Chengdu Institute of Biological Products Recent Developments
7 North America by Country
7.1 North America Pertussis Vaccine Sales by Country
7.1.1 North America Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Pertussis Vaccine Sales by Country (2019-2024)
7.1.3 North America Pertussis Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Pertussis Vaccine Market Size by Country
7.2.1 North America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Pertussis Vaccine Market Size by Country (2019-2024)
7.2.3 North America Pertussis Vaccine Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Pertussis Vaccine Sales by Country
8.1.1 Europe Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Pertussis Vaccine Sales by Country (2019-2024)
8.1.3 Europe Pertussis Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Pertussis Vaccine Market Size by Country
8.2.1 Europe Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Pertussis Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Pertussis Vaccine Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Pertussis Vaccine Sales by Country
9.1.1 Asia-Pacific Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Pertussis Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Pertussis Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Pertussis Vaccine Market Size by Country
9.2.1 Asia-Pacific Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Pertussis Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Pertussis Vaccine Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Pertussis Vaccine Sales by Country
10.1.1 Latin America Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Pertussis Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Pertussis Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Pertussis Vaccine Market Size by Country
10.2.1 Latin America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Pertussis Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Pertussis Vaccine Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Pertussis Vaccine Sales by Country
11.1.1 Middle East and Africa Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Pertussis Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Pertussis Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Pertussis Vaccine Market Size by Country
11.2.1 Middle East and Africa Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Pertussis Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Pertussis Vaccine Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Pertussis Vaccine Value Chain Analysis
12.1.1 Pertussis Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Pertussis Vaccine Production Mode & Process
12.2 Pertussis Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Pertussis Vaccine Distributors
12.2.3 Pertussis Vaccine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings